Holders · period archive

BCRX · Biocryst Pharmaceuticals Inc.

Q1 2019 13F holders

← latest ownership dossier

Ticker: BCRX
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares